These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24962756)

  • 21. The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings.
    Foppa IM; Ferdinands JM; Chaves SS; Haber MJ; Reynolds SB; Flannery B; Fry AM
    Int J Epidemiol; 2016 Dec; 45(6):2052-2059. PubMed ID: 26979985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Right sizing for vaccine effectiveness studies: how many is enough for reliable estimation?
    Price OH; Carville KS; Sullivan SG
    Commun Dis Intell (2018); 2019 May; 43():. PubMed ID: 31091402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12.
    Castilla J; Martínez-Baz I; Martínez-Artola V; Reina G; Pozo F; García Cenoz M; Guevara M; Morán J; Irisarri F; Arriazu M; Albéniz E; Ezpeleta C; Barricarte A; ;
    Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimates of influenza vaccine effectiveness in primary care in Scotland vary with clinical or laboratory endpoint and method--experience across the 2010/11 season.
    Kavanagh K; Robertson C; McMenamin J
    Vaccine; 2013 Sep; 31(41):4556-63. PubMed ID: 23933371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study.
    Kissling E; Valenciano M;
    Euro Surveill; 2011 Mar; 16(11):. PubMed ID: 21435329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results.
    Belongia EA; Kieke BA; Donahue JG; Coleman LA; Irving SA; Meece JK; Vandermause M; Lindstrom S; Gargiullo P; Shay DK
    Vaccine; 2011 Sep; 29(38):6558-63. PubMed ID: 21767593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the bias of estimates of influenza vaccine effectiveness from test-negative studies.
    Ainslie KEC; Shi M; Haber M; Orenstein WA
    Vaccine; 2017 Dec; 35(52):7297-7301. PubMed ID: 29146382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study.
    Kissling E; Valenciano M; Larrauri A; Oroszi B; Cohen JM; Nunes B; Pitigoi D; Rizzo C; Rebolledo J; Paradowska-Stankiewicz I; Jiménez-Jorge S; Horváth JK; Daviaud I; Guiomar R; Necula G; Bella A; O'Donnell J; Głuchowska M; Ciancio BC; Nicoll A; Moren A
    Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the test-negative and the traditional case-control study designs for estimation of influenza vaccine effectiveness under nonrandom vaccination.
    Shi M; An Q; Ainslie KEC; Haber M; Orenstein WA
    BMC Infect Dis; 2017 Dec; 17(1):757. PubMed ID: 29216845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza vaccine effectiveness for hospital and community patients using control groups with and without non-influenza respiratory viruses detected, Auckland, New Zealand 2014.
    Pierse N; Kelly H; Thompson MG; Bissielo A; Radke S; Huang QS; Baker MG; Turner N;
    Vaccine; 2016 Jan; 34(4):503-509. PubMed ID: 26685091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China.
    Yang P; Thompson MG; Ma C; Shi W; Wu S; Zhang D; Wang Q
    Vaccine; 2014 Sep; 32(41):5285-9. PubMed ID: 25092635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influenza vaccine effectiveness in the tropics: moderate protection in a case test-negative analysis of a hospital-based surveillance population in Bangkok between August 2009 and January 2013.
    Levy JW; Simasathien S; Watanaveeradej V; Bhoomiboonchoo P; Fernandez S; Jarman RG; Klungthong C; Gibbons RV; Kerdpanich P; Piboonbanakit D; Chirabandhu T; Yoon IK
    PLoS One; 2015; 10(8):e0134318. PubMed ID: 26267430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
    Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
    J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
    Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M
    J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.
    Skowronski DM; Janjua NZ; De Serres G; Winter AL; Dickinson JA; Gardy JL; Gubbay J; Fonseca K; Charest H; Crowcroft NS; Fradet MD; Bastien N; Li Y; Krajden M; Sabaiduc S; Petric M
    Clin Infect Dis; 2012 Aug; 55(3):332-42. PubMed ID: 22539661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.
    Skowronski DM; Masaro C; Kwindt TL; Mak A; Petric M; Li Y; Sebastian R; Chong M; Tam T; De Serres G
    Vaccine; 2007 Apr; 25(15):2842-51. PubMed ID: 17081662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants.
    Janjua NZ; Skowronski DM; De Serres G; Dickinson J; Crowcroft NS; Taylor M; Winter AL; Hottes TS; Fonseca K; Charest H; Drews SJ; Sabaiduc S; Bastien N; Li Y; Gardy JL; Petric M
    J Infect Dis; 2012 Jun; 205(12):1858-68. PubMed ID: 22492921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza vaccine effectiveness and disease burden in children and adolescents with sickle cell disease: 2012-2017.
    Kao CM; Lai K; McAteer JM; Elmontser M; Quincer EM; Yee MEM; Tippet A; Jerris RC; Lane PA; Anderson EJ; Bakshi N; Yildirim I
    Pediatr Blood Cancer; 2020 Aug; 67(8):e28358. PubMed ID: 32469138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010.
    Hardelid P; Fleming DM; McMenamin J; Andrews N; Robertson C; SebastianPillai P; Ellis J; Carman W; Wreghitt T; Watson JM; Pebody RG
    Euro Surveill; 2011 Jan; 16(2):. PubMed ID: 21251487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating Influenza Vaccine Effectiveness With the Test-Negative Design Using Alternative Control Groups: A Systematic Review and Meta-Analysis.
    Feng S; Cowling BJ; Kelly H; Sullivan SG
    Am J Epidemiol; 2018 Feb; 187(2):389-397. PubMed ID: 28641373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.